PROPERTIES OF HIV MEMBRANE RECONSTITUTED FROM ITS RECOMBINANT GP160 ENVELOPE GLYCOPROTEIN

被引:5
作者
CORNET, B [1 ]
DECROLY, E [1 ]
THINESSEMPOUX, D [1 ]
RUYSSCHAERT, JM [1 ]
VANDENBRANDEN, M [1 ]
机构
[1] UNIV CATHOLIQUE LOUVAIN,BIOL CELLULAIRE LAB,B-1348 LOUVAIN,BELGIUM
关键词
D O I
10.1089/aid.1992.8.1823
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human immunodeficiency virus (HIV) membrane has been reconstituted from the recombinant envelope glycoprotein precursor (gp160) by a detergent dialysis technique. Electron microscopy shows that gp160-virosomes are spherical vesicles with a mean diameter identical to that of viral particles. Enzyme-linked immunosorbent assay and immunogold labeling demonstrate efficient association of gp160 with lipid vesicles and proteolysis treatment reveals an asymmetric insertion with about 90% of glycoproteins having their gp120-moiety pointing outside. Glycoproteins are organized as dimers and tetramers and gp160 retains its ability to specifically bind CD4 receptor after reconstitution into virosome.
引用
收藏
页码:1823 / 1831
页数:9
相关论文
共 65 条
[1]   MAJOR GLYCOPROTEIN ANTIGENS THAT INDUCE ANTIBODIES IN AIDS PATIENTS ARE ENCODED BY HTLV-III [J].
ALLAN, JS ;
COLIGAN, JE ;
BARIN, F ;
MCLANE, MF ;
SODROSKI, JG ;
ROSEN, CA ;
HASELTINE, WA ;
LEE, TH ;
ESSEX, M .
SCIENCE, 1985, 228 (4703) :1091-1094
[2]   LIPID-COMPOSITION AND FLUIDITY OF THE HUMAN IMMUNODEFICIENCY VIRUS [J].
ALOIA, RC ;
JENSEN, FC ;
CURTAIN, CC ;
MOBLEY, PW ;
GORDON, LM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (03) :900-904
[3]   EFFECTIVENESS OF LIPOSOMES AS POTENTIAL CARRIERS OF VACCINES - APPLICATIONS TO CHOLERA-TOXIN AND HUMAN MALARIA SPOROZOITE ANTIGEN [J].
ALVING, CR ;
RICHARDS, RL ;
MOSS, J ;
ALVING, LI ;
CLEMENTS, JD ;
SHIBA, T ;
KOTANI, S ;
WIRTZ, RA ;
HOCKMEYER, WT .
VACCINE, 1986, 4 (03) :166-172
[4]   MAMMALIAN SUBTILISINS - THE LONG-SOUGHT DIBASIC PROCESSING ENDOPROTEASES [J].
BARR, PJ .
CELL, 1991, 66 (01) :1-3
[5]   ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS) [J].
BARRESINOUSSI, F ;
CHERMANN, JC ;
REY, F ;
NUGEYRE, MT ;
CHAMARET, S ;
GRUEST, J ;
DAUGUET, C ;
AXLERBLIN, C ;
VEZINETBRUN, F ;
ROUZIOUX, C ;
ROZENBAUM, W ;
MONTAGNIER, L .
SCIENCE, 1983, 220 (4599) :868-871
[6]   CONTROLLED ORGANIZATION OF MULTIMOLECULAR COMPLEXES OF ENVELOPED VIRUS GLYCOPROTEINS - STUDY OF IMMUNOGENICITY [J].
BEREZIN, VE ;
ZAIDES, VM ;
ISAEVA, ES ;
ARTAMONOV, AF ;
ZHDANOV, VM .
VACCINE, 1988, 6 (05) :450-456
[7]   POLYPEPTIDES OF MAMMALIAN ONCORNAVIRUSES .4. STRUCTURAL COMPONENTS OF MURINE LEUKEMIA-VIRUS RELEASED AS SOLUBLE-ANTIGENS IN CELL-CULTURE [J].
BOLOGNESI, DP ;
LANGLOIS, AJ ;
SCHAFER, W .
VIROLOGY, 1975, 68 (02) :550-555
[8]   MUTATIONAL ANALYSIS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENV GENE-PRODUCT PROTEOLYTIC CLEAVAGE SITE [J].
BOSCH, V ;
PAWLITA, M .
JOURNAL OF VIROLOGY, 1990, 64 (05) :2337-2344
[9]   MOUSE RESPONSE TO INFLUENZA IMMUNOSOMES [J].
BOUDREAULT, A ;
THIBODEAU, L .
VACCINE, 1985, 3 (03) :231-234
[10]  
Burny A., 1980, Viral oncology, P231